US combi product dispute guidance from FDA
This article was originally published in Clinica
Executive Summary
The US FDA has issued a guidance on filing dispute resolution requests when the agency fails to review and act on a combination product submission within the statutory time frame. In addition to noting who to contact and what to include in the request, the guidance explains when a formal request is appropriate and when it is not.